AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metgreat-G1 Tablet SR

Prescription Icon
Prescription Required

Marketer

NYG Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metgreat-G1 Tablet SR

Diabex Duo SR tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication assists in regulating blood glucose levels. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications such as kidney disease, vision impairment, neuropathy, and limb loss. Remember, this medication is a component of a broader treatment plan that necessitates a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Maintain regular mealtimes and carry readily available glucose sources, such as sugary snacks or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Metgreat-G1 Tablet SR

No text provided to rephrase.

Uses of Metgreat-G1 Tablet SR

Managing type 2 diabetes

Major Benefits of Metgreat-G1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metgreat-G1 SR tablets should be administered with a meal.

Common Side effects of Metgreat-G1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metgreat-G1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Metgreat-G1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with a meal.

How Metgreat-G1 Tablet SR works:

Metformin and Glimepiride, combined as Metgreat-G1 SR tablets, offer a dual approach to blood sugar management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Metgreat-G1 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metgreat-G1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Metgreat-G1 SR tablets is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Metgreat-G1 SR tablets cautiously, potentially requiring dosage modification under medical supervision. Metgreat-G1 SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Metgreat-G1 Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, Metgreat-G1 Tablet SR therapy typically begins with a reduced dose; however, it's contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Metgreat-G1 Tablet SR :

Should you forget a Metgreat-G1 Tablet SR dose, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metgreat-G1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metgreat-G1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metgreat-G1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Metgreat-G1 Tablet SR and seek immediate medical attention.
Metgreat-G1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Metgreat-G1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Metgreat-G1 Tablet SR use can lead to Vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Metgreat-G1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Metgreat-G1 Tablet SR and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise your risk of lactic acidosis.
Metgreat-G1 Tablet SR
68
MRP 79
13% off